Yazar "Tosun F.C." seçeneğine göre listele
Listeleniyor 1 - 7 / 7
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe F-18 FDG Pozitron Emisyon Tomografisi/Bilgisayarlı Tomografi ile Miyokardiyal Canlılık Görüntüleme Kılavuzu: Guidelines for Myocardial Viability Imaging with F-18 FDG(Galenos Publishing House, 2020) Özdemir S.; Başoğlu T.; Demir H.; Altun G.D.; Özdemir E.; Şen F.; Tosun F.C.Myocardial viability imaging with Fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT), in patients who are appropriate for coronary revascularization, in the presence of left ventricular dysfunction and rest myocardial perfusion defect due to coronary artery disease, has become a frequently used method to differentiate viable myocardial (hibernating) and non-viable myocardial tissues (scar). This guideline, has been prepared by Turkey Society of Nuclear Medicine Cardiology Working Group to provide a standart approach to cardiac viability imaging with F-18 FDG PET/CT. For this purpose details on instrumentation and reporting are summarized and all presented suggestions are submitted by evaluating the international guidelines and current literature. © Telif Hakkı 2020 Türkiye Nükleer Tıp Derneği / Nükleer Tıp Seminerleri, Galenos Yayınevi tarafından yayınlanmıştır.Öğe Iodine-123 Meta-iodobenzylguanidine Cardiac Innervation Imaging Guideline(Galenos Publishing House, 2020) Altun G.D.; Serim B.D.; Özdemir E.; Özdemir S.; Şen F.; Demir H.; Tosun F.C.Sympathetic innervation of the heart plays an important role in the pathophysiology of diseases, especially congestive heart failure and arrhythmias. Iodine-123 metaiodobenzylguanidine (I-123 MIBG) scintigraphy allows for early detection of problems by imaging at the neurotransmitter level before cardiac structural changes occur. In this way, it is possible to correctly manage the diagnosis and treatment processes of the patients. The main purpose of this guide is to ensure the national standardization of cardiac I-123 MIBG scintigraphy applications. In addition, it is intended to guide nuclear medicine doctors in the proper execution of indications, imaging and clinical processes, evaluation and reporting stages. © Telif Hakkı 2020 Türkiye Nükleer Tıp Derneği / Nükleer Tıp Seminerleri, Galenos Yayınevi tarafından yayınlanmıştır.Öğe Myocardial Perfusion SPECT Procedure Guideline(Galenos Publishing House, 2020) Tosun F.C.; Özdemir S.; Şen F.; Demir H.; Özdemir E.; Altun G.D.After Turkish Society of Nuclear Medicine “Cardiology Group” had first published “Nuclear Cardiology Practice Guidelines” in 2001, in line particular with the technological developments, significant changes both in the hardware, software and also in the protocols have occurred in the era of nuclear cardiology. Besides many new clinical uses in nuclear cardiology and specific developments in both single photon emission computerized tomography and positron emission tomography systems, such as specific cardiac gamma camera systems and blood flow studies, myocardial perfusion scintigraphy (MPS), which is still performed today mostly with conventional gamma camera systems, ranks first among both nuclear cardiology and also general conventional nuclear medicine procedures in almost all nuclear medicine clinics. The aim of this guideline is to assist nuclear medicine physicians in MPS studies, in terms of indications, application, imaging methods, evaluation and reporting stages. The recommendations in this guide has been prepared by “Turkish Society of Nuclear Medicine Cardiology Task Group” to ensure the standardization of the MPS applications in our country in the light of international studies and current guidelines. © Telif Hakkı 2020 Türkiye Nükleer Tıp Derneği / Nükleer Tıp Seminerleri, Galenos Yayınevi tarafından yayınlanmıştır.Öğe Nuclear medicine procedures in diagnosis of infective endocarditis(Galenos Publishing House, 2020) Demir H.; Tosun F.C.; Altun G.D.; Özdemir E.; Özdemir S.; Şen F.Infective endocarditis (IE) is described as infection of endocardial surfaces of heart and if available prosthesis materials. Despite all up to date developments in diagnosis and treatment of its, IE is mortal and morbid disease. IE causes numerous non-specific symptoms and findings in patients. Currently, various difficulties are observed in diagnosis and differential diagnosis of IE. Duke criteria is used for supporting of diagnosis. Also, echocardiography, computerized tomography (CT), positron emission tomography (PET)/CT, magnetic resonance, labeled leukocyte scintigraphy, blood culture, polymerase chain reaction investigations are used. Although, histopathological diagnosis is gold standard. In this procedure guideline nuclear medicine methods (PET/CT and labeled leukocyte scintigraphy) will be handled that used more frequently in recent years for diagnosis of IE. © Telif Hakkı 2020 Türkiye Nükleer Tıp Derneği / Nükleer Tıp Seminerleri, Galenos Yayınevi tarafından yayınlanmıştır.Öğe Procedure guideline for detection of inflammation with F-18 FDG PET/CT in cardiac sarcoidosis(Galenos Publishing House, 2020) Sen F.; Demir H.; Altun G.D.; Özdemir E.; Özdemir S.; Tosun F.C.Histologic confirmation of cardiac sarcoidosis (CS) is challenging. When taken into account of either the invasive nature or potential false negativity of the endomyocardial biopsy, imaging methods represent as a major alternative to establish a clinical diagnosis. Among the imaging methods, the use of fluorine-18-fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) which detects active inflammation in CS is becoming widespread. Recently, F-18 FDG PET has been identified as one of the new diagnostic criteria in CS, by the Heart Rhythm Society. For diagnosis, a combination of both myocardial perfusion and inflammation findings should be interpreted visually and/or semiquantitatively. Yet, the precision of diagnostic accuracy has been limited by lack of an adequate reference standard. This procedure guideline presents current literature defining the role of F-18 FDG PET in the diagnosis and management of CS along with technical details and recommendations about imaging protocol and interpretation. © 2020 Nuclear Medicine Seminars. All Rights Reserved.Öğe Procedure Guideline for Scintigraphic Imaging in Cardiac Transthyretin Amyloidosis(Galenos Publishing House, 2020) Özdemir E.; Tosun F.C.; Altun G.D.; Demir H.; Özdemir S.; Şen F.Amyloidosis is a multisystem disease that results from extracellular deposition of amyloid fibriles in tissue and cardiac involvement may be seen. Cardiac amyloidosis is a rare and mostly underdiagnosed cause of heart failure. Several types of amyloid can infiltrate the myocardium. Diagnosis is usually made with endomyocardial biopsy. Scintigraphic imaging with Technetium (Tc-99m) labelled biphosponates may facilitate early detection of cardiac involvement and distinguish various forms of cardiac amyloidosis. The aim of this guideline is to assist nuclear medicine physicians in recommending, imaging, reporting and interpreting the results of scintigraphy with Tc-99m labelled bone radiopharmaceuticals for the evaluation of transthyretin cardiac amyloidosis. © Telif Hakkı 2020 Türkiye Nükleer Tıp Derneği / Nükleer Tıp Seminerleri, Galenos Yayınevi tarafından yayınlanmıştır.Öğe Standardized Reporting of Myocardial Perfusion SPECT Imaging(Galenos Publishing House, 2020) Tosun F.C.; Demir H.; Taşçı C.; Özdemir E.; Özdemir S.; Şen F.; Altun G.D.Myocardial perfusion single photon emission computerized tomography (MPS) report is the final product of a series of complex procedures, starting with patient preparation and ending with interpretation of the process. The report should summarize the patient’s identity, the purpose(s) of the test, all the procedures, drugs and radiopharmaceuticals performed, and the characteristics of the practicing physician and clinic as much as clearly possible. The aim of this guide is to assist nuclear physicians in MPS studies, especially during the reporting phase.The recommendations in this guide were prepared by “Turkey Society of Nuclear Medicine Cardiology Task Group”, to ensure the standardization of our MPS reporting in our country, considering the developments and contribution of the structured reporting into the clinical practice in the light of international studies and current guidelines. © Telif Hakkı 2020 Türkiye Nükleer Tıp Derneği
